GNRH1 and obesity disorder: discovered that obesity impacts oocyte quality in GnRH agonist long protocols, while BMI does not affect oocyte number and maturity in HMG+CC protocols, suggesting that mild ovarian stimulation may be more suitable for women with obesity (33).